Clean Yield Group’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-600
Closed -$16K 489
2021
Q2
$16K Buy
+600
New +$16.3K 0.01% 337
2021
Q1
Sell
-600
Closed -$12K 412
2020
Q4
$12K Hold
600
﹤0.01% 339
2020
Q3
$10K Sell
600
-2,740
-82% -$51.8K ﹤0.01% 308
2020
Q2
$73K Sell
3,340
-940
-22% -$21.5K 0.03% 186
2020
Q1
$99K Sell
4,280
-1,450
-25% -$42.1K 0.05% 153
2019
Q4
$189K Hold
5,730
0.06% 144
2019
Q3
$182K Sell
5,730
-1,890
-25% -$55.1K 0.06% 145
2019
Q2
$196K Sell
7,620
-8,820
-54% -$225K 0.07% 130
2019
Q1
$417K Sell
16,440
-40,220
-71% -$1.2M 0.17% 91
2018
Q4
$1.93M Sell
56,660
-2,845
-5% -$92.5K 0.84% 47
2018
Q3
$2.12M Buy
59,505
+550
+0.9% +$19.4K 0.84% 47
2018
Q2
$2.03M Sell
58,955
-240
-0.4% -$8.41K 0.84% 46
2018
Q1
$1.99M Buy
+59,195
New +$1.87M 0.84% 45

Other funds holding NTUS

Clean Yield Group's NTUS Position: Q3 2021 in Review

Clean Yield Group sold out of Natus Medical Inc (NTUS) in Q3 2021, closing a stake of 600 shares — an estimated $16K sold.

Clean Yield Group first reported a position in NTUS in Q1 2018 and held it in 13 quarters. The position peaked at $2.12M in Q3 2018. 169 funds tracked by Wall St. Rank hold NTUS as of Q3 2021.

  • Clean Yield Group reported no remaining Natus Medical Inc position as of Q3 2021 after selling out during the quarter.
  • Clean Yield Group sold 600 Natus Medical Inc shares in Q3 2021, an estimated $16K.
  • Clean Yield Group first reported a position in Natus Medical Inc in Q1 2018 and held it in 13 quarters.
  • Clean Yield Group's Natus Medical Inc position peaked at $2.12M in Q3 2018.
  • 169 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2021.

Based on Clean Yield Group's 13F filing for Q3 2021, filed 27 Oct 2021.